Kevin T. Conroy is CEO & President at EXACT SCIENCES CORP (EXAS). They have made 73 open-market trades across 2 companies since 2006, most recently 2026-09-23.
CIK 0001306119
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
15 open-market purchases totalling $1.4M since 2006, against 58 sales. Across 7 scored buys the stock is up 5.2% at ninety days, and 3.9 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 29% | 100% | 100% |
| Avg Move | -12.8% | +8.4% | +5.2% |
| Alpha | -9.0% | +7.5% | +3.9% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EXAS | BUY | 2024-11-13 | 2024-11-13 | $51.35 | $1.0M | +10.1% | +22.3% | +1.9% |
| EXAS | SELL · 10b5-1 | 2024-05-01 | 2024-05-02 | $60.15 | $139K | -13.6% | -28.3% | -26.9% |
| EXAS | SELL · 10b5-1 | 2024-03-01 | 2024-03-04 | $59.32 | $981K | +0.1% | +24.5% | -23.4% |
| EXAS | SELL · 10b5-1 | 2024-02-27 | 2024-02-28 | $56.89 | $713K | +6.4% | +23.4% | -17.6% |
| EXAS | SELL · 10b5-1 | 2024-02-22 | 2024-02-23 | $59.78 | $1.4M | -1.3% | +11.8% | -5.2% |
| EXAS | SELL · 10b5-1 | 2024-02-21 | 2024-02-22 | $61.50 | $612K | -2.1% | +6.7% | -10.5% |
| EXAS | SELL · 10b5-1 | 2024-02-15 | 2024-02-16 | $61.43 | $1.8M | -4.1% | -1.9% | -13.4% |
| EXAS | SELL | 2023-02-28 | 2023-03-01 | $61.12 | $1.3M | +3.6% | +10.6% | +32.3% |
| EXAS | SELL | 2023-02-22 | 2023-02-23 | $62.72 | $598K | +10.0% | +11.2% | +37.3% |
| EXAS | SELL | 2023-02-15 | 2023-02-16 | $65.59 | $1.9M | -0.1% | +1.5% | +25.8% |
| EXAS | SELL | 2023-02-13 | 2023-02-14 | $64.55 | $584K | -7.5% | +1.7% | +24.4% |
| EXAS | SELL · 10b5-1 | 2022-07-01 | 2022-07-06 | $40.75 | $285 | +4.8% | +8.8% | -16.4% |
| EXAS | SELL | 2022-03-01 | 2022-03-02 | $76.69 | $2.2M | -22.5% | -0.2% | -34.2% |
| EXAS | SELL | 2022-02-24 | 2022-02-25 | $70.10 | $3.8M | -8.2% | -13.8% | -36.7% |
| EXAS | SELL | 2022-02-23 | 2022-02-24 | $69.05 | $716K | -4.8% | -9.9% | -35.7% |
| EXAS | SELL | 2022-02-15 | 2022-02-16 | $79.55 | $2.3M | -1.1% | -13.4% | -30.0% |
| EXAS | SELL | 2021-11-01 | 2021-11-03 | $93.88 | $3.2M | -4.4% | -18.6% | -17.7% |
| EXAS | SELL | 2021-10-01 | 2021-10-05 | $93.64 | $3.2M | +8.2% | +7.8% | -10.9% |
| EXAS | SELL | 2021-09-01 | 2021-09-03 | $104.42 | $4.0M | -4.6% | -13.5% | -25.2% |
| EXAS | SELL | 2021-08-02 | 2021-08-04 | $107.50 | $2.1M | -11.9% | +2.2% | -9.5% |
| EXAS | SELL | 2021-07-01 | 2021-07-06 | $123.43 | $1.9M | -7.0% | -11.9% | -24.0% |
| EXAS | SELL | 2021-06-01 | 2021-06-03 | $111.00 | $1.4M | +12.9% | +12.3% | -2.6% |
| EXAS | SELL | 2021-05-03 | 2021-05-05 | $131.09 | $5.0M | -13.0% | -1.8% | -4.2% |
| EXAS | SELL | 2021-04-01 | 2021-04-05 | $132.30 | $6.0M | -1.5% | -16.5% | -7.9% |
| EXAS | SELL | 2021-03-02 | 2021-03-03 | $138.42 | $2.7M | +2.5% | +5.8% | -14.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $156.3M |
Shares reported on the most recent Form 4, priced at the 2026-09-25 close. 2 holdings could not be priced and are excluded from the total.